Michael Majors, President and CEO
Cambridge Major Laboratories.
What makes Cambridge Major successful in an era where manufacturing is generally on the decline in the U.S.? According to Michael Major, it’s strong R&D. At Cambridge Major, a significant amount of R&D supports early scale-up during pre-clinical development. From that point, the company works closely with clients from molecular concept to the in-human study phase as a priority.
Ten years later and hot on the heels of a major (yes, pun intended) $40 million expansion that has already added 60 new jobs in the region and expanded processing capacity from 3,000 to 18,000 gallons, Cambridge Major eyes a future with sales doubling their current annual figure of around $50 million. read more
|